How Pharma and Medtech should respond to new EU rules on R&D on biological resources

Research output: Contribution to journalJournal article

  • Bart Van Vooren
Original languageEnglish
JournalScrip Regulatory Affairs
Pages (from-to)2-5
Number of pages4
ISSN2047-9727
Publication statusPublished - May 2016

ID: 162384750